NanoViricides: Big Things In a Small Package
During an interview with OneMedPlace, President and Chairman of NanoViricides (NNVC) Anil Diwan summed up the influenza treatment market in just a few words: It is like trying to hit a moving target.
influenza
News Medical: iBio Launch Platform Creates H7N9 Influenza Vaccine in Record Time
Influenza is a virus that is constantly changing and requires routine monitoring. Without the proper preparation, this advanced virus could develop in to a pandemic. IBio has produced a vaccine candidate for the newly emerging H7N9 influenza virus in a milestone time of 21 days.
For Vax Providers, Flu Season Off to a Running Start
It’s flu season again, and more than 690,000 people in the U.S. have already been vaccinated, reports healthcare analytics service SDI.
Chembio Diagnostics Tackles Infectious Diseases with Rapid-Diagnostic Platform
Chembio Diagnostics specializes in the development of advanced diagnostic tests for infectious diseases such as HIV and syphilis.
The Universal Vaccines of Inovio Biomedical
Inovio is developing a universal flu vaccine engineered to prevent several strains of influenza at once.
As Seasonal Flu Ramps Up, NexBio Begins Phase II Trial for DAS181
DAS181 is formulated to prevent the influenza virus from entering cells in the respiratory tract.
First Swine Flu Vaccines Approved
The U.S. government has approved swine flu vaccines from four pharmaceutical companies, Reuters reports.
GSK and Enigma Pair Up to Develop Influenza Diagnostics
The new test would analyze swab samples and return a diagnosis in less than 60 minutes.
Companies Rush to Create Swine Flu Vaccines
With flu season approaching, the U.S. federal government has earmarked nearly $1 billion for the development of swine flu vaccines.